...
首页> 外文期刊>ACS Omega >Mechanisms and Control Measures of Mature Biofilm Resistance to Antimicrobial Agents in the Clinical Context
【24h】

Mechanisms and Control Measures of Mature Biofilm Resistance to Antimicrobial Agents in the Clinical Context

机译:临床背景下成熟生物膜抗性药物抗菌药物的机理及控制措施

获取原文
           

摘要

Biofilms are the aggregation of micro-organisms, which are composed of extracellular polymeric substance (EPS) and many other biochemical components. Though they might be beneficial to some wastewater and soil treatment processes, they may expose chronic infection and risk to personal hygiene in the industrial as well as the clinical context. Despite having a well-established disinfection and hygiene monitoring program for the prevention of formation and growth, biofilm persistently remains in the medical settings because of its antibiotic resistance to antimicrobial agents and even the immune system. In this paper, the contributing factors of antibiotic resistance and the corresponding mechanisms, including heterogeneity inside biofilms, the roles of the EPS matrix, cell density, and quorum sensing, and cell mutability, are reviewed. Moreover, current clinical practice and strategic applications are also suggested to address the biofilm resistance issues.
机译:生物膜是微生物的聚集,其由细胞外聚合物物质(EPS)和许多其他生物化学成分组成。虽然它们可能对一些废水和土壤处理过程有益,但它们可能会使工业和临床环境中的个人卫生以及临床环境暴露慢性感染和风险。尽管具有良好的消毒和卫生监测计划,但防止形成和生长,生物膜持续存在于医疗环境中,因为其对抗微生物剂甚至免疫系统甚至是免疫系统。在本文中,综述了抗生素抗性和相应机制的抗生素抗性的贡献因子,包括异质性,eps基质,细胞密度和法定感测和细胞变形性的作用。此外,还提出了目前的临床实践和战略应用来解决生物膜阻力问题。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号